Status:
COMPLETED
Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Aventis Pharmaceuticals
Conditions:
Ovarian Carcinoma
Primary Peritoneal Carcinoma
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer
Eligibility Criteria
Inclusion
- Recurrent ovarian or peritoneal cancer
Exclusion
- No prior chemotherapy
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00214058
Start Date
August 1 2002
End Date
February 1 2006
Last Update
November 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792